Dermata Therapeutics, Inc.
USD1.30
-0.00 (-0.04%)
CEO
Gerald T. Proehl
IPO Date
2021-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.27
Prev. Close
$1.30
Day Low
$1.25
Day High
$1.33
52W Low
$1.10
52W High
$8.00
Market Cap
$0.00B
Volume
0.14M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -122.7% | -97.7% | 0.00 | 4.91 | -0.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -159.6% | -138.4% | 0.00 | 7.53 | -7.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -78.2% | -68.0% | 0.00 | 7.66 | -27.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 101.8% | -534.6% | -1.12 | 0.16 | -13.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 2246.6% | -228.5% | -6.11 | 1.20 | -9.2 |
| -0.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -42.7% | -33.4% | 0.00 | 4.56 | -0.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -30.3% | -25.6% | 0.00 | 15.67 | -0.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -31.6% | -23.0% | 0.00 | 3.70 | -0.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -201.8% | -89.2% | 0.00 | 1.79 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -66.9% | -47.5% | 0.00 | 3.44 | -0.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -85.3% | -54.0% | 0.00 | 2.73 | -0.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -82.3% | -60.5% | 0.00 | 3.78 | -0.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -33.6% | -26.7% | 0.00 | 4.91 | -4.2 |